Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Rigel Pharmaceuticals, Inc. (RIGL) had Debt to Capital Ratio of 0.04 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$58.82M |
|
$8.65M |
|
$4.61M |
|
$54.21M |
|
$46.93M |
|
$11.88M |
|
$-0.23M |
|
$11.66M |
|
$11.66M |
|
$8.65M |
|
$8.65M |
|
$8.65M |
|
$8.65M |
|
$11.88M |
|
$12.31M |
|
18.41M |
|
19.69M |
|
$0.47 |
|
$0.44 |
|
| Balance Sheet Financials | |
$234.03M |
|
-- |
|
$270.58M |
|
$504.61M |
|
$89.49M |
|
$14.99M |
|
$15.22M |
|
$104.71M |
|
$399.90M |
|
$375.74M |
|
$399.90M |
|
18.48M |
|
| Cash Flow Statement Financials | |
$2.73M |
|
$-7.97M |
|
$-10.92M |
|
$40.64M |
|
$24.47M |
|
$-16.17M |
|
$3.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.62 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.04 |
0.11 |
|
92.17% |
|
20.21% |
|
20.21% |
|
-- |
|
19.82% |
|
14.71% |
|
$2.73M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.40 |
|
1.18 |
|
76.42 |
|
2.16% |
|
2.30% |
|
1.72% |
|
2.09% |
|
$21.64 |
|
$0.14 |
|
$0.14 |
|